{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-006000","form_type":"8-K","ticker":"SMTI","cik":"0000714256","company_name":"Sanara MedTech Inc.","filed_at":"2023-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.844089+00:00","generated_at":"2026-06-19T01:02:15.269751+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Sanara MedTech enters $75M at-the-market equity offering agreement with Cantor Fitzgerald","bullets":["Up to $75M of common stock may be sold from time to time through Cantor Fitzgerald & Co.","Cantor receives a 3.0% commission on gross proceeds from each sale.","Sales are at-the-market offerings under Rule 415(a)(4); no obligation to sell any shares.","Agreement may be suspended or terminated by either party upon notice.","Shares are registered under existing S-3 shelf registration statement (File No. 333-251652)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-006000","json":"https://secwatch.observer/filing/0001493152-23-006000.json","markdown":"https://secwatch.observer/filing/0001493152-23-006000.md","text":"https://secwatch.observer/filing/0001493152-23-006000.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/714256/000149315223006000/0001493152-23-006000-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/714256/000149315223006000/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T01:02:15.269751+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"08c6c53676e6730fb4a45edfb62240c3878bbba2","claim":"Sanara MedTech Inc. entered into Sales Agreement with Cantor Fitzgerald & Co. valued at up to $75,000,000 (effective 2023-02-24).","evidence_excerpt":"On February 24, 2023, Sanara MedTech Inc., a Texas corporation (the “Company”), entered into a Controlled Equity Offering SM Sales Agreement (the “Sales Agreement”) with Cantor Fitzgerald & Co., as sales agent (“Cantor”), pursuant to which the Company may offer and sell from time to time, to or through Cantor, shares of the Company’s common stock, par value $0.001 per share, having an aggregate offering price of up to $75,000,000 (the “Shares”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/714256/000149315223006000/0001493152-23-006000-index.htm","confidence":1.0,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Cantor Fitzgerald & Co."},{"label":"Value","value":"up to $75,000,000"},{"label":"Effective","value":"2023-02-24"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}